Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms

British Journal of Haematology

Volumn 148, Issue 2, 2010, Pages 268-273

  Hidalgo Curtis, Claire ^a   Apperley, Jane F ^b   Stark, Anthony ^c   Jeng, Michael ^d   Gotlib, Jason ^e   Chase, Andrew ^a   Cross, Nicholas C P ^a   Grand, Francis H ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Chromosomal rearrangements; Imatinib; PDGFRB

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; COMPLEMENTARY DNA; CORTICOSTEROID; GENE PRODUCT; HYDROXYUREA; IMATINIB; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BIN2; PROTEIN GOLGA4; PROTEIN WDR48; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BONE MARROW TUMOR; CANCER INHIBITION; CANCER PATIENT; CASE REPORT; CHILD; CHROMOSOME 12Q; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; EOSINOPHILIA; ERYTHEMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DISRUPTION; GENE FUSION; GENE LOCUS; HUMAN; INTRACELLULAR TRANSPORT; LEUKOCYTOSIS; MALE; MYELOPROLIFERATIVE DISORDER; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; TREATMENT RESPONSE; TUMOR GROWTH;

AGED; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

EID: 72649103374     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07955.x     Document Type: Article

References (19)

1. Apperley, J.F., Gardembas, M., Melo, J.V., Russell-Jones, R., Bain, B.J., Baxter, E.J., Chase, A., Chessells, J.M., Colombat, M., Dearden, C.E., Dimitrijevic, S., Mahon, F.X., Marin, D., Nikolova, Z., Olavarria, E., Silberman, S., Schultheis, B., Cross, N.C. Goldman, J.M. (2002) Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. New England Journal of Medicine, 347, 481 487.
2. Baxter, E.J., Kulkarni, S., Vizmanos, J.L., Jaju, R., Martinelli, G., Testoni, N., Hughes, G., Salamanchuk, Z., Calasanz, M.J., Lahortiga, I., Pocock, C.F., Dang, R., Fidler, C., Wainscoat, J.S., Boultwood, J. Cross, N.C. (2003) Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. British Journal of Haematology, 120, 251 256.
3. Chen, C.Y. Brodsky, F.M. (2005) Huntingtin-interacting protein 1 (Hip1) and Hip1-related protein (Hip1R) bind the conserved sequence of clathrin light chains and thereby influence clathrin assembly in vitro and actin distribution in vivo. Journal of Biological Chemistry, 280, 6109 6117.
4. Cross, N.C. Reiter, A. (2002) Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia, 16, 1207 1212.
5. David, M., Cross, N.C., Burgstaller, S., Chase, A., Curtis, C., Dang, R., Gardembas, M., Goldman, J.M., Grand, F., Hughes, G., Huguet, F., Lavender, L., McArthur, G.A., Mahon, F.X., Massimini, G., Melo, J., Rousselot, P., Russell-Jones, R.J., Seymour, J.F., Smith, G., Stark, A., Waghorn, K., Nikolova, Z. Apperley, J.F. (2007) Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders. Blood, 109, 61 64.
6. De Keersmaecker, K. Cools, J. (2006) Chronic myeloproliferative disorders: a tyrosine kinase tale. Leukemia, 20, 200 205.
7. Delaval, B., Létard, S., Lelièvre, H., Chevrier, V., Daviet, L., Dubreuil, P. Birnbaum, D. (2005) Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome. Cancer Research, 65, 7231 7240.
8. Gallagher, G., Horsman, D.E., Tsang, P. Forrest, D.L. (2008) Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders. Cancer Genetics and Cytogenetics, 181, 46 51.
9. Ge, K. Prendergast, G.C. (2000) Bin2, a functionally nonredundant member of the BAR adaptor gene family. Genomics, 67, 210 220.
10. Ge, K., DuHadaway, J., Du, W., Herlyn, M., Rodeck, U. Prendergast, G.C. (1999) Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proceedings of the National Academy of Sciences of the United States of America, 96, 9689 9694.
11. Grand, F.H., Burgstaller, S., Kühr, T., Baxter, E.J., Webersinke, G., Thaler, J., Chase, A.J. Cross, N.C. (2004) p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder. Cancer Research, 64, 7216 7219.
12. Hidalgo-Curtis, C., Chase, A., Drachenberg, M., Roberts, M.W., Finkelstein, J.Z., Mould, S., Oscier, D., Cross, N.C. Grand, F.H. (2008) The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes, Chromosomes and Cancer, 47, 379 385.
13. Jones, A.V. Cross, N.C. (2004) Oncogenic derivatives of platelet-derived growth factor receptors. Cellular and Molecular Life Sciences, 61, 2912 2923.
14. Magnusson, M.K., Meade, K.E., Brown, K.E., Arthur, D.C., Krueger, L.A., Barrett, A.J. Dunbar, C.E. (2001) Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. Blood, 98, 2518 2525.
15. Olabisi, O.O., Mahon, G.M., Kostenko, E.V., Liu, Z., Ozer, H.L. Whitehead, I.P. (2006) Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Research, 66, 6250 6257.
16. Park, J., Lee, B.S., Choi, J.K., Means, R.E., Choe, J. Jung, J.U. (2002) Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression. Immunity, 17, 221 233.
17. Saint-Dic, D., Chang, S.C., Taylor, G.S., Provot, M.M. Ross, T.S. (2001) Regulation of the Src homology 2-containing inositol 5-phosphatase SHIP1 in HIP1/PDGFbeta R-transformed cells. Journal of Biological Chemistry, 276, 21192 21198.
18. Thornton, C., Tang, K.C., Phamluong, K., Luong, K., Vagts, A., Nikanjam, D., Yaka, R. Ron, D. (2004) Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization. Journal of Biological Chemistry, 279, 31357 31364.
19. Vizmanos, J.L., Novo, F.J., Román, J.P., Baxter, E.J., Lahortiga, I., Larráyoz, M.J., Odero, M.D., Giraldo, P., Calasanz, M.J. Cross, N.C. (2004) NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder. Cancer Research, 64, 2673 2676.